Partial long-term clinical improvement after a BCG challenge in systemic lupus erythematosus-prone mice

• Auteurs principaux: Valentina P. Mora (Auteur), Francisco B. Quero (Auteur), Tays Troncoso-Bravo (Auteur), Claudia Orellana (Auteur), Patricia Pereira (Auteur), Juan P. Mackern-Oberti (Auteur), Samanta C. Funes (Auteur), Jorge A. Soto (Auteur), Karen Bohmwald (Auteur), Susan M. Bueno (Auteur), Alexis M. Kalergis (Auteur)
• Format: Livre
• Publié: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Systemic Lupus Erythematosus (SLE) is an autoimmune disorder that causes a breakdown of immune tolerance. Current treatments mainly involve general immunosuppression, increasing the risk of infections. On the other hand, Bacillus Calmette-Guérin (BCG) has been investigated as a potential therapy fo...